查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930169

全球生物偶联市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的考察、未来预测（2026-2034）

Bioconjugation Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 220 Pages | 商品交期: 请询问到货日

价格

生物偶联市场成长因素

2025年全球生物偶联市场规模达47.8亿美元，从2026年的52.4亿美元成长至2034年的113.9亿美元，预测期内年复合成长率（CAGR）为10.20%。北美地区凭藉着强大的生物製药研发活动和先进的生产能力，在2025年占据生物偶联市场51.82%的市场占有率，成为该市场的主导地区。

生物偶联是一种将两种不同的分子（通常透过共价键）化学连接起来，形成功能性复合物的技术。这项技术广泛应用于抗体药物偶联物（ADC）、诊断试剂、分子影像剂和标靶治疗药物的研发。对标靶治疗日益成长的需求、研发投入的增加以及技术的不断进步，加速生物偶联技术在治疗和诊断领域的应用。此外，生物製药公司与合约研究、开发和生产机构（CRO/CDMO）之间合作的加强，也进一步推动了市场成长。

Thermo Fisher Scientific Inc.、Agilent Technologies Inc.、Lonza等领导企业凭藉其广泛的服务、全球营运和强大的技术能力，引领市场。

市场动态

市场驱动因素

对抗体药物偶联物（ADC）的日益关注

对抗体药物偶联物（ADC）研发的日益关注是生物偶联市场的主要驱动因素。抗体偶联药物（ADC）结合了单株抗体的特异性和细胞毒性药物的效力，能够以较低的全身毒性进行标靶癌症治疗。位点特异性偶联技术的进步提高了药物的稳定性、疗效和安全性，扩展了 ADC 的研发管线。

根据Hunan Huateng Pharmaceutical Co., Ltd.2025年 4月发布的资料，截至目前，全球共有 19 种 ADC 药物已获批上市。

市场限制因子

监理与安全挑战

严格的法规要求和安全问题是限制市场成长的重要因素。新型生物偶联药物由于存在脱靶毒性和药物过早释放等风险，面临复杂的监管路径。这些因素可能会延长审批时间并增加研发成本，可能延缓商业化进程。

例如，2023年 7月，ADC Therapeutics SA 因安全性和有效性问题终止了 II 期 LOTIS-9 试验。

市场机会

伴随诊断及影像剂需求成长

生物偶联透过将成像探针、放射性同位素和萤光染料连接到抗体或胜肽上，在精准诊断和分子成像中发挥关键作用。伴随诊断和成像剂（尤其是在肿瘤学领域）的日益普及，为市场带来了巨大的成长机会。

市场挑战

高成本与技术复杂性

开发生物偶联疗法，特别是抗体药物偶联物（ADC），需要复杂的生产流程、先进的设施和广泛的临床试验。根据美国国家生物技术资讯中心（NCBI）2023年 6月的一项研究，抗体偶联药物（ADC）疗法的年费用在 10万美元至 50万美元之间，这限制了该疗法的普及和广泛应用。

生物偶联市场趋势

外包给 CRO 和 CDMO 的趋势日益明显

製药和生物技术公司日益将偶联和表征活动外包给专业的CRO（合约研究组织）和 CDMO（合约开发和生产组织）。这一趋势使公司能够降低资本支出、获得先进技术并加快开发进程。2024年 10月，龙沙公司扩大了与一家大型生物製药公司在商业规模 ADC 生产方面的合作。

市场区隔分析

依产品/服务分类：

产品细分市场在2026年占据主导地位，市场占有率达75.83%，主要得益于药物研发、诊断和研究领域对耗材的高需求。

依技术分类：

化学偶联技术细分市场在2026年占据最大市场占有率，达47.68%，这主要归功于其成本效益和广泛的适用性。

依偶联物类型划分：

抗体药物偶联物（ADC）在强大的肿瘤产品线支持下，预计到2026年将占据 56.91%的市场占有率。

依应用领域划分：

受标靶疗法获准数量不断增加的推动，治疗药物领域占据主导地位，到2025年达到 66.0%，预计到2026年将达到 66.74%。

依最终使用者划分：

由于製药和生技公司高度重视创新疗法的研发，到2025年，它们将占据 56.7%的市场占有率。

区域展望

北美地区凭藉强劲的研发投入和完善的合约研究组织/合约研发产量组织（CRO/CDMO）生态系统，引领市场，2025年市场规模达到24.8亿美元，2026年将达到27.2亿美元。

欧洲地区2025年市场规模达到12.3亿美元，年复合成长率（CAGR）为9.82%。

亚太地区预计2026年市场规模将达8.4亿美元，其中中国和印度分别达到1.5亿至1.6亿美元。

拉丁美洲地区2025年市场规模达到4.19亿美元，中东和非洲（GCC）地区达到6,000万美元。

目录

第1章 引言

第2章 执行摘要

第3章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第4章 主要考察

  • 生物偶联技术进展
  • 主要国家的监管状况
  • 主要产业趋势：併购、业务合作等
  • 主要公司新产品发布
  • 概述：拓展生物偶联的应用

第5章 全球生物偶联市场分析：洞察与预测（2021-2034）

  • 依产品类型划分的市场分析、洞察与预测
    • 产品
      • 设备
      • 耗材
    • 服务
      • 客製化合成与偶联服务
      • 分析与表征服务
      • 放大生产服务
      • 其他
  • 依技术划分的市场分析、洞察与预测
    • 化学偶联
    • 酶促偶联
    • 点击化学
    • 光反应交联
    • 其他
  • 依偶联物类型划分的市场分析、洞察与预测
    • 抗体药物偶联物偶联物（ADC）
    • 蛋白质-药物偶联物
    • 胜肽-药物偶联物
    • 其他
  • 市场分析、洞察与预测：依应用领域划分
    • 治疗药物
    • 诊断
    • 研发（R&D）
  • 市场分析、洞察与预测：依最终用户划分
    • 製药和生技公司
    • 合约研究组织（CRO）与合约研发生产力组织（CDMO）
    • 学术和研究机构
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第6章 北美生物偶联市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第7章 欧洲生物偶联市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第8章 亚太生物偶联市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 东南亚
    • 亚太其他地区

第9章 拉丁美洲生物偶联市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家

第10章 中东与非洲生物偶联市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • GCC成员国
    • 南非
    • 其他中东和非洲国家

第11章 竞争分析

  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • Bio Rad Laboratories Inc.
  • Merck KGaA
  • Lonza
  • Catalent, Inc.
  • BD
  • Sartorius AG
  • Danaher
  • Vector Laboratories, Inc.
Product Code: FBI114238

Growth Factors of bioconjugation Market

The global bioconjugation market size was valued at USD 4.78 billion in 2025 and is projected to grow from USD 5.24 billion in 2026 to USD 11.39 billion by 2034, registering a CAGR of 10.20% during the forecast period. North America dominated the bioconjugation market with a market share of 51.82% in 2025, supported by strong biopharmaceutical R&D activities and advanced manufacturing capabilities.

Bioconjugation refers to the chemical linking of two distinct molecules, typically through covalent bonding, to create a functional complex. This technology is widely used in the development of antibody-drug conjugates (ADCs), diagnostics, molecular imaging agents, and targeted therapeutics. Rising demand for targeted therapies, increasing R&D investments, and continuous technological advancements are accelerating the adoption of bioconjugation across therapeutic and diagnostic applications. Additionally, increasing collaborations between biopharmaceutical companies and contract research and manufacturing organizations (CROs/CDMOs) are further supporting market growth.

Major players such as Thermo Fisher Scientific Inc., Agilent Technologies Inc., and Lonza dominate the market owing to their broad service offerings, global presence, and strong technological capabilities.

MARKET DYNAMICS

MARKET DRIVERS

Increasing Focus on Antibody-Drug Conjugates (ADCs)

The growing emphasis on the development of antibody-drug conjugates is a key driver of the bioconjugation market. ADCs combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs, enabling targeted cancer treatment with reduced systemic toxicity. Advancements in site-specific conjugation technologies have improved drug stability, efficacy, and safety profiles, leading to an expanding pipeline of ADCs.

According to data published by Hunan Huateng Pharmaceutical Co., Ltd. in April 2025, a total of 19 ADC drugs have been approved globally to date.

MARKET RESTRAINTS

Regulatory and Safety Challenges

Stringent regulatory requirements and safety concerns pose significant restraints on market growth. Novel bioconjugates face complex regulatory pathways due to risks such as off-target toxicity and premature drug release. These factors result in longer approval timelines and increased development costs, potentially delaying commercialization.

For instance, in July 2023, ADC Therapeutics SA discontinued the Phase II LOTIS-9 trial due to safety and efficacy concerns.

MARKET OPPORTUNITIES

Growing Demand for Companion Diagnostics and Imaging Agents

Bioconjugation plays a crucial role in precision diagnostics and molecular imaging by enabling the attachment of imaging probes, radioactive isotopes, and fluorescent dyes to antibodies or peptides. The increasing adoption of companion diagnostics and imaging agents, particularly in oncology, presents significant growth opportunities for the market.

MARKET CHALLENGES

High Cost and Technical Complexity

The development of bioconjugated therapeutics, especially ADCs, involves complex manufacturing processes, sophisticated equipment, and extensive clinical trials. According to a June 2023 NCBI study, the annual cost of ADC therapy ranges between USD 100,000 and USD 500,000, which limits accessibility and adoption.

BIOCONJUGATION MARKET TRENDS

Rising Outsourcing to CROs and CDMOs

Pharmaceutical and biotechnology companies are increasingly outsourcing conjugation and characterization activities to specialized CROs and CDMOs. This trend allows companies to reduce capital expenditure, access advanced technologies, and accelerate development timelines. In October 2024, Lonza expanded its collaboration with a major biopharmaceutical company for commercial-scale ADC manufacturing.

SEGMENTATION ANALYSIS

By Offering:

The products segment dominated the market with a 75.83% share in 2026, driven by high demand for consumables used in drug development, diagnostics, and research.

By Technique:

The chemical conjugation segment held the largest share at 47.68% in 2026, owing to its cost-effectiveness and wide applicability.

By Conjugate Type:

Antibody-drug conjugates (ADCs) accounted for 56.91% of the market in 2026, supported by strong oncology pipelines.

By Application:

The therapeutics segment dominated with 66.0% share in 2025 and 66.74% in 2026, driven by increasing approvals of targeted therapies.

By End User:

Pharmaceutical & biotechnology companies held 56.7% share in 2025, supported by strong focus on innovative therapeutic development.

REGIONAL OUTLOOK

North America led the market with USD 2.48 billion in 2025 and USD 2.72 billion in 2026, driven by strong R&D investments and a robust CRO/CDMO ecosystem.

Europe reached USD 1.23 billion in 2025, growing at a CAGR of 9.82%.

Asia Pacific attained USD 0.84 billion in 2026, with China and India each reaching USD 0.15-0.16 billion.

Latin America recorded USD 0.419 billion in 2025, while Middle East & Africa (GCC) reached USD 0.06 billion.

COMPETITIVE LANDSCAPE

The bioconjugation market is semi-consolidated, with leading players such as Thermo Fisher Scientific Inc., Merck KGaA, Lonza, Danaher, and Catalent, Inc. focusing on expanding conjugation capabilities, ADC pipelines, and service offerings. Strategic investments and collaborations continue to strengthen competitive positioning.

Conclusion

The global bioconjugation market is positioned for strong growth, driven by rising demand for targeted therapeutics, expanding ADC pipelines, and increasing outsourcing to specialized CROs and CDMOs. With the market valued at USD 4.78 billion in 2025, expected to reach USD 5.24 billion in 2026 and USD 11.39 billion by 2034, sustained innovation and strategic collaborations will remain key growth enablers. Despite regulatory and cost-related challenges, advancements in conjugation technologies and growing applications in diagnostics and therapeutics are expected to support consistent market expansion over the forecast period.

Segmentation By Offering, Technique, Conjugate Type, Application, End User, and Region

By Offering * Products

    • Instruments
      • Chromatography Systems
      • Spectroscopy Instruments
      • Mass Spectrometers
      • Flow Cytometers
      • Others
    • Consumables
      • Reagents & Kits
      • Labels
      • Others
  • Services
    • Custom Synthesis & Conjugation Services
    • Analytical & Characterization Services
    • Scale-up & Manufacturing Services
    • Others

By Technique * Chemical Conjugation

  • Enzyme-Mediated Conjugation
  • Click Chemistry
  • Photoreactive Crosslinking
  • Others

By Conjugate Type * Antibody-Drug Conjugates (ADCs)

  • Protein-Drug Conjugates
  • Peptide-Drug Conjugates
  • Others

By Application * Therapeutics

  • Diagnostics
  • Research & Development

By End User * Pharmaceutical & Biotechnology Companies

  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

By Region * North America (By Offering, Technique, Conjugate Type, Application, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Technique, Conjugate Type, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Bioconjugation
  • 4.2. Regulatory Scenario, By Key Countries/Regions
  • 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
  • 4.4. New Product Launches, By Key Players
  • 4.5. Overview: Expanding Applications of Bioconjugation

5. Global Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Chromatography Systems
        • 5.1.1.1.2. Spectroscopy Instruments
        • 5.1.1.1.3. Mass Spectrometers
        • 5.1.1.1.4. Flow Cytometers
        • 5.1.1.1.5. Others
      • 5.1.1.2. Consumables
        • 5.1.1.2.1. Reagents & Kits
        • 5.1.1.2.2. Labels
        • 5.1.1.2.3. Others
    • 5.1.2. Services
      • 5.1.2.1. Custom Synthesis & Conjugation Services
      • 5.1.2.2. Analytical & Characterization Services
      • 5.1.2.3. Scale-up & Manufacturing Services
      • 5.1.2.4. Others
  • 5.2. Market Analysis, Insights and Forecast - By Technique
    • 5.2.1. Chemical Conjugation
    • 5.2.2. Enzyme-Mediated Conjugation
    • 5.2.3. Click Chemistry
    • 5.2.4. Photoreactive Crosslinking
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 5.3.1. Antibody-Drug Conjugates (ADCs)
    • 5.3.2. Protein-Drug Conjugates
    • 5.3.3. Peptide-Drug Conjugates
    • 5.3.4. Others
  • 5.4. Market Analysis, Insights and Forecast - By Application
    • 5.4.1. Therapeutics
    • 5.4.2. Diagnostics
    • 5.4.3. Research & Development
  • 5.5. Market Analysis, Insights and Forecast - By End User
    • 5.5.1. Pharmaceutical & Biotechnology Companies
    • 5.5.2. CROs & CDMOs
    • 5.5.3. Academic & Research Institutes
    • 5.5.4. Others
  • 5.6. Market Analysis, Insights and Forecast - By Region
    • 5.6.1. North America
    • 5.6.2. Europe
    • 5.6.3. Asia Pacific
    • 5.6.4. Latin America
    • 5.6.5. Middle East & Africa

6. North America Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Chromatography Systems
        • 6.1.1.1.2. Spectroscopy Instruments
        • 6.1.1.1.3. Mass Spectrometers
        • 6.1.1.1.4. Flow Cytometers
        • 6.1.1.1.5. Others
      • 6.1.1.2. Consumables
        • 6.1.1.2.1. Reagents & Kits
        • 6.1.1.2.2. Labels
        • 6.1.1.2.3. Others
    • 6.1.2. Services
      • 6.1.2.1. Custom Synthesis & Conjugation Services
      • 6.1.2.2. Analytical & Characterization Services
      • 6.1.2.3. Scale-up & Manufacturing Services
      • 6.1.2.4. Others
  • 6.2. Market Analysis, Insights and Forecast - By Technique
    • 6.2.1. Chemical Conjugation
    • 6.2.2. Enzyme-Mediated Conjugation
    • 6.2.3. Click Chemistry
    • 6.2.4. Photoreactive Crosslinking
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 6.3.1. Antibody-Drug Conjugates (ADCs)
    • 6.3.2. Protein-Drug Conjugates
    • 6.3.3. Peptide-Drug Conjugates
    • 6.3.4. Others
  • 6.4. Market Analysis, Insights and Forecast - By Application
    • 6.4.1. Therapeutics
    • 6.4.2. Diagnostics
    • 6.4.3. Research & Development
  • 6.5. Market Analysis, Insights and Forecast - By End User
    • 6.5.1. Pharmaceutical & Biotechnology Companies
    • 6.5.2. CROs & CDMOs
    • 6.5.3. Academic & Research Institutes
    • 6.5.4. Others
  • 6.6. Market Analysis, Insights and Forecast - By Country
    • 6.6.1. U.S.
    • 6.6.2. Canada

7. Europe Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Chromatography Systems
        • 7.1.1.1.2. Spectroscopy Instruments
        • 7.1.1.1.3. Mass Spectrometers
        • 7.1.1.1.4. Flow Cytometers
        • 7.1.1.1.5. Others
      • 7.1.1.2. Consumables
        • 7.1.1.2.1. Reagents & Kits
        • 7.1.1.2.2. Labels
        • 7.1.1.2.3. Others
    • 7.1.2. Services
      • 7.1.2.1. Custom Synthesis & Conjugation Services
      • 7.1.2.2. Analytical & Characterization Services
      • 7.1.2.3. Scale-up & Manufacturing Services
      • 7.1.2.4. Others
  • 7.2. Market Analysis, Insights and Forecast - By Technique
    • 7.2.1. Chemical Conjugation
    • 7.2.2. Enzyme-Mediated Conjugation
    • 7.2.3. Click Chemistry
    • 7.2.4. Photoreactive Crosslinking
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 7.3.1. Antibody-Drug Conjugates (ADCs)
    • 7.3.2. Protein-Drug Conjugates
    • 7.3.3. Peptide-Drug Conjugates
    • 7.3.4. Others
  • 7.4. Market Analysis, Insights and Forecast - By Application
    • 7.4.1. Therapeutics
    • 7.4.2. Diagnostics
    • 7.4.3. Research & Development
  • 7.5. Market Analysis, Insights and Forecast - By End User
    • 7.5.1. Pharmaceutical & Biotechnology Companies
    • 7.5.2. CROs & CDMOs
    • 7.5.3. Academic & Research Institutes
    • 7.5.4. Others
  • 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.6.1. U.K.
    • 7.6.2. Germany
    • 7.6.3. France
    • 7.6.4. Spain
    • 7.6.5. Italy
    • 7.6.6. Scandinavia
    • 7.6.7. Rest of Europe

8. Asia Pacific Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Chromatography Systems
        • 8.1.1.1.2. Spectroscopy Instruments
        • 8.1.1.1.3. Mass Spectrometers
        • 8.1.1.1.4. Flow Cytometers
        • 8.1.1.1.5. Others
      • 8.1.1.2. Consumables
        • 8.1.1.2.1. Reagents & Kits
        • 8.1.1.2.2. Labels
        • 8.1.1.2.3. Others
    • 8.1.2. Services
      • 8.1.2.1. Custom Synthesis & Conjugation Services
      • 8.1.2.2. Analytical & Characterization Services
      • 8.1.2.3. Scale-up & Manufacturing Services
      • 8.1.2.4. Others
  • 8.2. Market Analysis, Insights and Forecast - By Technique
    • 8.2.1. Chemical Conjugation
    • 8.2.2. Enzyme-Mediated Conjugation
    • 8.2.3. Click Chemistry
    • 8.2.4. Photoreactive Crosslinking
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 8.3.1. Antibody-Drug Conjugates (ADCs)
    • 8.3.2. Protein-Drug Conjugates
    • 8.3.3. Peptide-Drug Conjugates
    • 8.3.4. Others
  • 8.4. Market Analysis, Insights and Forecast - By Application
    • 8.4.1. Therapeutics
    • 8.4.2. Diagnostics
    • 8.4.3. Research & Development
  • 8.5. Market Analysis, Insights and Forecast - By End User
    • 8.5.1. Pharmaceutical & Biotechnology Companies
    • 8.5.2. CROs & CDMOs
    • 8.5.3. Academic & Research Institutes
    • 8.5.4. Others
  • 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.6.1. Japan
    • 8.6.2. China
    • 8.6.3. India
    • 8.6.4. Australia
    • 8.6.5. Southeast Asia
    • 8.6.6. Rest of Asia Pacific

9. Latin America Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Chromatography Systems
        • 9.1.1.1.2. Spectroscopy Instruments
        • 9.1.1.1.3. Mass Spectrometers
        • 9.1.1.1.4. Flow Cytometers
        • 9.1.1.1.5. Others
      • 9.1.1.2. Consumables
        • 9.1.1.2.1. Reagents & Kits
        • 9.1.1.2.2. Labels
        • 9.1.1.2.3. Others
    • 9.1.2. Services
      • 9.1.2.1. Custom Synthesis & Conjugation Services
      • 9.1.2.2. Analytical & Characterization Services
      • 9.1.2.3. Scale-up & Manufacturing Services
      • 9.1.2.4. Others
  • 9.2. Market Analysis, Insights and Forecast - By Technique
    • 9.2.1. Chemical Conjugation
    • 9.2.2. Enzyme-Mediated Conjugation
    • 9.2.3. Click Chemistry
    • 9.2.4. Photoreactive Crosslinking
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 9.3.1. Antibody-Drug Conjugates (ADCs)
    • 9.3.2. Protein-Drug Conjugates
    • 9.3.3. Peptide-Drug Conjugates
    • 9.3.4. Others
  • 9.4. Market Analysis, Insights and Forecast - By Application
    • 9.4.1. Therapeutics
    • 9.4.2. Diagnostics
    • 9.4.3. Research & Development
  • 9.5. Market Analysis, Insights and Forecast - By End User
    • 9.5.1. Pharmaceutical & Biotechnology Companies
    • 9.5.2. CROs & CDMOs
    • 9.5.3. Academic & Research Institutes
    • 9.5.4. Others
  • 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.6.1. Brazil
    • 9.6.2. Mexico
    • 9.6.3. Rest of Latin America

10. Middle East & Africa Bioconjugation Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Chromatography Systems
        • 10.1.1.1.2. Spectroscopy Instruments
        • 10.1.1.1.3. Mass Spectrometers
        • 10.1.1.1.4. Flow Cytometers
        • 10.1.1.1.5. Others
      • 10.1.1.2. Consumables
        • 10.1.1.2.1. Reagents & Kits
        • 10.1.1.2.2. Labels
        • 10.1.1.2.3. Others
    • 10.1.2. Services
      • 10.1.2.1. Custom Synthesis & Conjugation Services
      • 10.1.2.2. Analytical & Characterization Services
      • 10.1.2.3. Scale-up & Manufacturing Services
      • 10.1.2.4. Others
  • 10.2. Market Analysis, Insights and Forecast - By Technique
    • 10.2.1. Chemical Conjugation
    • 10.2.2. Enzyme-Mediated Conjugation
    • 10.2.3. Click Chemistry
    • 10.2.4. Photoreactive Crosslinking
    • 10.2.5. Others
  • 10.3. Market Analysis, Insights and Forecast - By Conjugate Type
    • 10.3.1. Antibody-Drug Conjugates (ADCs)
    • 10.3.2. Protein-Drug Conjugates
    • 10.3.3. Peptide-Drug Conjugates
    • 10.3.4. Others
  • 10.4. Market Analysis, Insights and Forecast - By Application
    • 10.4.1. Therapeutics
    • 10.4.2. Diagnostics
    • 10.4.3. Research & Development
  • 10.5. Market Analysis, Insights and Forecast - By End User
    • 10.5.1. Pharmaceutical & Biotechnology Companies
    • 10.5.2. CROs & CDMOs
    • 10.5.3. Academic & Research Institutes
    • 10.5.4. Others
  • 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.6.1. GCC
    • 10.6.2. South Africa
    • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products & Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
    • 11.2.1. Agilent Technologies Inc.
    • 11.2.2. Thermo Fisher Scientific Inc.
    • 11.2.3. Bio Rad Laboratories Inc.
    • 11.2.4. Merck KGaA
    • 11.2.5. Lonza
    • 11.2.6. Catalent, Inc.
    • 11.2.7. BD
    • 11.2.8. Sartorius AG
    • 11.2.9. Danaher
    • 11.2.10. Vector Laboratories, Inc.

List of Tables

  • Table 1: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 2: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 3: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 4: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 5: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 6: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 7: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 8: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 9: Global Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 10: Global Bioconjugation Market Revenue (USD Billion) Forecast, By Region, 2021-2034
  • Table 11: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 12: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 13: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 14: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 15: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 16: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 17: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 18: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 19: North America Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 20: North America Bioconjugation Market Revenue (USD Billion) Forecast, By Country, 2021-2034
  • Table 21: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 22: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 23: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 24: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 25: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 26: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 27: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 28: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 29: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 30: Europe Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 31: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 32: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 33: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 34: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 35: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 36: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 37: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 38: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 39: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 40: Asia Pacific Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 41: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 42: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 43: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 44: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 45: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 46: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 47: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 48: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 49: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 50: Latin America Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 51: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Offering, 2021-2034
  • Table 52: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Products, 2021-2034
  • Table 53: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Instruments, 2021-2034
  • Table 54: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Consumables, 2021-2034
  • Table 55: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Services, 2021-2034
  • Table 56: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Technique, 2021-2034
  • Table 57: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Conjugate Type, 2021-2034
  • Table 58: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Application, 2021-2034
  • Table 59: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By End User, 2021-2034
  • Table 60: Middle East & Africa Bioconjugation Market Revenue (USD Billion) Forecast, By Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Bioconjugation Market Revenue Breakdown (USD Billion, %) By Region, 2025 & 2034
  • Figure 2: Global Bioconjugation Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Bioconjugation Market Value Share (%), By Technique, 2025 & 2034
  • Figure 4: Global Bioconjugation Market Value Share (%), By Conjugate Type, 2025 & 2034
  • Figure 5: Global Bioconjugation Market Value Share (%), By Application, 2025 & 2034
  • Figure 6: Global Bioconjugation Market Value Share (%), By End User, 2025 & 2034
  • Figure 7: Global Bioconjugation Market Value (USD Billion), By Region, 2025 & 2034
  • Figure 8: North America Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 9: North America Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 10: North America Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 12: North America Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 12: North America Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 13: North America Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 14: North America Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 15: North America Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 16: North America Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 17: North America Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 18: North America Bioconjugation Market Value (USD Billion), By Country, 2025 & 2034
  • Figure 19: North America Bioconjugation Market Value Share (%), By Country, 2025
  • Figure 20: Europe Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 21: Europe Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 22: Europe Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 23: Europe Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 24: Europe Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 25: Europe Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 26: Europe Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 27: Europe Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 28: Europe Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 29: Europe Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 30: Europe Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 31: Europe Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 32: Asia Pacific Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 33: Asia Pacific Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 34: Asia Pacific Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 35: Asia Pacific Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 36: Asia Pacific Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 37: Asia Pacific Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 38: Asia Pacific Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 39: Asia Pacific Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 40: Asia Pacific Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 41: Asia Pacific Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 42: Asia Pacific Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 43: Asia Pacific Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 44: Latin America Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 45: Latin America Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 46: Latin America Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 47: Latin America Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 48: Latin America Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 49: Latin America Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 50: Latin America Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 51: Latin America Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 52: Latin America Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 53: Latin America Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 54: Latin America Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 55: Latin America Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 56: Middle East & Africa Bioconjugation Market Value (USD Billion), By Offering, 2025 & 2034
  • Figure 57: Middle East & Africa Bioconjugation Market Value Share (%), By Offering, 2025
  • Figure 58: Middle East & Africa Bioconjugation Market Value (USD Billion), By Technique, 2025 & 2034
  • Figure 59: Middle East & Africa Bioconjugation Market Value Share (%), By Technique, 2025
  • Figure 60: Middle East & Africa Bioconjugation Market Value (USD Billion), By Conjugate Type, 2025 & 2034
  • Figure 61: Middle East & Africa Bioconjugation Market Value Share (%), By Conjugate Type, 2025
  • Figure 62: Middle East & Africa Bioconjugation Market Value (USD Billion), By Application, 2025 & 2034
  • Figure 63: Middle East & Africa Bioconjugation Market Value Share (%), By Application, 2025
  • Figure 64: Middle East & Africa Bioconjugation Market Value (USD Billion), By End User, 2025 & 2034
  • Figure 65: Middle East & Africa Bioconjugation Market Value Share (%), By End User, 2025
  • Figure 66: Middle East & Africa Bioconjugation Market Value (USD Billion), By Country/ Sub-region, 2025 & 2034
  • Figure 67: Middle East & Africa Bioconjugation Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 68: Global Bioconjugation Market Share (%), By Company, 2025